SET悬吊训练结合生物反馈技术在卒中患者下肢运动功能训练中的疗效观察  

Observation on the Efficacy of SET Suspension Training Combined with Biofeedback Technology in Lower Limb Motor Function Trainingof Stroke Patients

作　　者：李旭锋 邓桂芬 陈礼彬 Li Xufeng(Department of Rehabilitation,Nanhai Fifth People’s Hospital,Foshan City,Foshan Guangdong 525439)

机构地区：[1]佛山市南海区第五人民医院康复科,广东佛山525439

出　　处：《黑龙江医药》2024年第5期1059-1062,共4页Heilongjiang Medicine journal

基　　金：佛山市卫生健康局医学科研课题(课题编号:20240056)。

摘　　要：目的:探讨SET悬吊训练结合生物反馈技术在卒中患者下肢运动功能训练中的疗效。方法:选取佛山市南海区第五人民医院2022年1月—2023年12月期间收治的卒中下肢运动功能障碍患者72例为研究对象,分为2组,对照组(36例,实施SET悬吊训练)和实验组(36例,SET悬吊训练结合生物反馈技术),比较两组干预效果。结果:治疗后,实验组患者肌张力低于对照组;治疗后,实验组患者运动功能(FMA)评分、平衡功能(BBS)评分高于对照组(P<0.05)。结论:SET悬吊训练结合生物反馈技术对改善卒中患者下肢运动功能具有积极意义,有效改善患者的神经肌肉控制、降低肌张力、增强平衡和运动功能,进而提高其生活质量,值得推广和实施。Objective:To explore the therapeutic effect of SET suspension training combined with biofeedback technology on lower limb motor function training in stroke patients.Methods:72 stroke patients with lower limb motor dysfunction admitted to the Fifth People’s Hospital of Nanhai District,Foshan City from January 2022 to December 2023 were selected as the study subjects.They were divided into two groups:a control group(36 cases,receiving SET suspension training)and an experimental group(36 cases,receiving SET suspension training combined with biofeedback technology).The intervention effects of the two groups were compared.Results:After treatment,the muscle tone of the experimental group patients was lower than that of the control group;After treatment,the motor function(FMA)and balance function(BBS)scores of the experimental group were higher than those of the control group(P<0.05).Conclusion:The combination of SET suspension training and biofeedback technology has a positive significance in improving the lower limb motor function of stroke patients,effectively improving their neuromuscular control,reducing muscle tone,enhancing balance and motor function,and thereby improving their quality of life.It is worth promoting and implementing.

关 键 词：SET悬吊训练 生物反馈技术 卒中 下肢运动功能 疗效 

分 类 号：R743.33[医药卫生—神经病学与精神病学]